Physician Global Assessment (PGA) and Psoriasis Area and Severity Index (PASI): Why do both? A?systematic analysis of randomized controlled trials of biologic agents for moderate to severe plaque psoriasis-Reference-Cited by-同舟云学术

Physician Global Assessment (PGA) and Psoriasis Area and Severity Index (PASI): Why do both? A?systematic analysis of randomized controlled trials of biologic agents for moderate to severe plaque psoriasis

Published:2012-03 Issue:3 Volume:66 Page:369-375
ISSN:0190-9622
Container-title:Journal of the American Academy of Dermatology
language:en
Short-container-title:Journal of the American Academy of Dermatology

Author:

Robinson Amanda,Kardos Marisa,Kimball Alexandra B.

Publisher

Elsevier BV

Subject

Dermatology

Reference41 articles.

1. How good are clinical severity and outcome measures for psoriasis? Quantitative evaluation in a systematic review;Spuls;J Invest Dermatol,2010

2. What are the best outcome measures for assessing plaque psoriasis severity? A?systematic review of the literature;Puzenat;J Eur Acad Dermatol Venereol,2010

3. Department of Health and Human Services. Public Health Service. Food and Drug Administration. Dermatologic and Ophthalmic Drugs Advisory Committee 49th Meeting. March 20, 1998.

4. Clinical severity of psoriasis in the last 20 years of PUVA study;Nijsten;Arch Dermatol,2007

5. Methotrexate versus cyclosporine in moderate-to-severe chronic plaque psoriasis;Heydendael;N Engl J Med,2003

Cited by 156 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Understanding Barriers Impacting upon Patient Wellbeing: A Nationwide Italian Survey and Expert Opinion of Dermatologists Treating Patients with Moderate-to-Severe Psoriasis;Journal of Clinical Medicine;2023-12-24

2. A systematic review investigating at what proportion clinical images are shared in prospective randomized controlled trials involving patients with psoriasis and biological agents;Journal of Dermatological Treatment;2023-11-15

3. Modulatory role of vitamins A, B3, C, D, and E on skin health, immunity, microbiome, and diseases;Pharmacological Reports;2023-09-06

4. Novel Psoriasis Treatment: Development and Evaluation of a Thermo-Sensitive Pro-Penetrating Hydrogel Based on Coptis chinensis and Phellodendron amurense;Revista Brasileira de Farmacognosia;2023-08-15

5. Achievement and maintenance of therapeutic response to brodalumab in patients with moderate‐to‐severe plaque psoriasis: An Italian, observational, retrospective and prospective study (BRIGHT study);JEADV Clinical Practice;2023-06-30